Lemborexant
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Lemborexant is used to treat sleep initiation and maintenance disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 7, 2020. In 2024, Medicare Part D spent $21 million on Lemborexant across 58,000 claims for 15,000 beneficiaries.
Lemborexant is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $11.58 to $11.58 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$11.58 – $11.58
per EA
7d Activity
avg -0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing LEMBOREXANT
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DAYVIGO 5 MG TABLET | $11.5802 per EA | -0.02% |
DAYVIGO 10 MG TABLET | $11.5794 per EA | -0.02% |
Frequently Asked Questions
What is Lemborexant used to treat?
Lemborexant is used to treat sleep initiation and maintenance disorders, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Lemborexant?
In 2024, Medicare Part D spent $21 million on Lemborexant across 58,000 claims for 15,000 beneficiaries.
How many Lemborexant products are on the market?
The Lemborexant drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Lemborexant?
NADAC reference prices for Lemborexant range from $11.5794 to $11.5802 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Lemborexant?
1 manufacturer lists Lemborexant in NADAC. Ranked by number of NDCs, the largest are Eisai Inc. (2).
How has the price of Lemborexant changed recently?
Over the past 7 days, 0 Lemborexant NDCs rose and 2 fell, with a market-wide average change of -0.0%.